PRC-063 in an ADULT Workplace Environment

Clinical trial NCT02225639 · COMPLETED

Trial details

NCT number: NCT02225639
Sponsor: Rhodes Pharmaceuticals, L.P.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder (ADHD)

Start date: 2014-08-01
Primary completion: 2015-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.